Your browser doesn't support javascript.
loading
Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
Holmgren, J; Bourgeois, L; Carlin, N; Clements, J; Gustafsson, B; Lundgren, A; Nygren, E; Tobias, J; Walker, R; Svennerholm, A-M.
Affiliation
  • Holmgren J; University of Gothenburg Vaccine Research Institute (GUVAX), Department of Microbiology and Immunology, University of Gothenburg, Box 435, 405 30 Gothenburg, Sweden. jan.holmgren@microbio.gu.se
Vaccine ; 31(20): 2457-64, 2013 May 07.
Article in En | MEDLINE | ID: mdl-23541621

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Toxins / Vaccines, Inactivated / Adjuvants, Immunologic / Cholera Toxin / Escherichia coli Vaccines / Escherichia coli Proteins / Fimbriae Proteins / Enterotoxins / Enterotoxigenic Escherichia coli Type of study: Evaluation_studies Language: En Journal: Vaccine Year: 2013 Document type: Article Affiliation country: Sweden Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bacterial Toxins / Vaccines, Inactivated / Adjuvants, Immunologic / Cholera Toxin / Escherichia coli Vaccines / Escherichia coli Proteins / Fimbriae Proteins / Enterotoxins / Enterotoxigenic Escherichia coli Type of study: Evaluation_studies Language: En Journal: Vaccine Year: 2013 Document type: Article Affiliation country: Sweden Country of publication: Netherlands